Fund shareholders of Boston Scientific Corp
ISIN US1011371077 · United States · LEI Y6ZDD9FP4P8JSSJMW954
- Fund shareholders
- 1,158
- Of which ETFs
- 258 900 other funds
- Value held
- 30.6B $ 6.5B SEK · 47.1M €
- Share of capital
- 33.4 % of 1.4B shares on Jul 30, 2026
1,158 funds hold this company. This table lists the 1,136 that declare it in a regulatory filing. The other 22 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| UNIÓN INVERSORA PATRIMONIAL, SICAV S.A EDM GESTION, SOCIEDAD ANONIMA, S.G.I.I.C. | 887.3K € | 2.10 % | as of Dec 31, 2025 ↗ | ||
| EDM RENTA VARIABLE INTERNACIONAL, FI EDM GESTION, SOCIEDAD ANONIMA, S.G.I.I.C. | 883.7K € | 2.53 % | as of Dec 31, 2025 ↗ | ||
| INVERSIONES TEIDE, S.A. SICAV URQUIJO GESTION, S.A., S.G.I.I.C., SOCIEDAD UNIPERSONAL | 873.1K € | 1.02 % | as of Dec 31, 2025 ↗ | ||
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 835.7K € | 4.69 % | as of Dec 31, 2025 ↗ | ||
| DB BOLSA GLOBAL, FI DEUTSCHE WEALTH MANAGEMENT SGIIC, S.A. | 779.6K € | 0.39 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 632.9K € | 1.62 % | as of Dec 31, 2025 ↗ | ||
| BBVA BOLSA INDICE USA (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 603K € | 0.23 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 ACTIVOS GLOBALES, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 600.7K € | 0.60 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 MEGATENDENCIAS, FI RENTA 4 MEGATENDENCIAS / SALUD, INNOVACIÓN Y BIOTECNOLOGÍA MÉDICA RENTA 4 GESTORA, S.G.I.I.C., S.A. | 434.4K € | 2.18 % | as of Dec 31, 2025 ↗ | ||
| PARADOX EQUITY FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 374.2K € | 1.73 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 EEUU ACCIONES, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 288.5K € | 1.46 % | as of Dec 31, 2025 ↗ | ||
| BINDEX USA SCREENED ÍNDICE (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 282K € | 0.34 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 GLOBAL ACCIONES, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 272.6K € | 0.53 % | as of Dec 31, 2025 ↗ | ||
| FUTURVALOR, SICAV S.A. GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 263.8K € | 0.85 % | as of Dec 31, 2025 ↗ | ||
| SAGEI, S.A., SICAV EDM GESTION, SOCIEDAD ANONIMA, S.G.I.I.C. | 255.1K € | 2.54 % | as of Dec 31, 2025 ↗ | ||
| FOMENTO DE AHORROS E INVERSIONES, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 214.9K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 209.9K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| IBERCAJA CONFIANZA SOSTENIBLE, FI IBERCAJA GESTION, SGIIC, S.A. | 186.7K € | 0.18 % | as of Dec 31, 2025 ↗ | ||
| MAGNUS GLOBAL FLEXIBLE, SICAV, S.A. GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 180.2K € | 1.56 % | as of Dec 31, 2025 ↗ | ||
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 178.6K € | 1.34 % | as of Dec 31, 2025 ↗ | ||
| INVERSIONES FINANCIERAS JUPEDAL, SICAV, SA SANTANDER ASSET MANAGEMENT, S.A., SGIIC | 176.7K € | 0.21 % | as of Dec 31, 2025 ↗ | ||
| INVERCLASSIC INVESTMENT, SICAV SA GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 162.4K € | 0.41 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 156.1K € | 0.06 % | as of Dec 31, 2025 ↗ | ||
| FINECO INVESTMENT OFFICE, FI FINECO INVESTMENT OFFICE/SCHRODERS G.I.I.C. FINECO, S.A., S.G.I.I.C. | 115.4K € | 0.11 % | as of Dec 31, 2025 ↗ | ||
| COMPROMISO MEDIOLANUM, FI MEDIOLANUM GESTION, S.G.I.I.C., S.A. | 110.7K € | 0.27 % | as of Dec 31, 2025 ↗ | ||
| QUANTICA XXII, SICAV, S.A. GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 105.7K € | 1.59 % | as of Dec 31, 2025 ↗ | ||
| BANKINTER ETHOS, FI BANKINTER GESTION DE ACTIVOS, S.A., S.G.I.I.C. | 101.4K € | 0.33 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 91.5K € | 2.49 % | as of Dec 31, 2025 ↗ | ||
| CLARIZON CAPITAL, FI INVERSIS GESTIÓN, S.A., SGIIC | 89.8K € | 0.71 % | as of Dec 31, 2025 ↗ | ||
| GLOBAL MIX FUND, F.I. SOLVENTIS S.G.I.I.C., S.A. | 89.3K € | 0.63 % | as of Dec 31, 2025 ↗ | ||
| GVC GAESCO CROSSOVER, FI GVC GAESCO CROSSOVER-GARP RVMI GVC GAESCO GESTIÓN, SGIIC, S.A. | 81.1K € | 1.78 % | as of Dec 31, 2025 ↗ | ||
| MAGNUS INTERNATIONAL ALLOCATION, FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 76K € | 0.79 % | as of Dec 31, 2025 ↗ | ||
| ROLAVI INVERSIONES, SICAV S.A. SANTANDER ASSET MANAGEMENT, S.A., SGIIC | 59.2K € | 1.01 % | as of Dec 31, 2025 ↗ | ||
| SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 56.7K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 55.8K € | 0.08 % | as of Dec 31, 2025 ↗ | ||
| FONDO ETICO EDUCA 5.0, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 31.7K € | 0.36 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Select Medical Technology and Devices Portfolio Fidelity Select Portfolios | 12.32 % | as of Feb 28, 2026 ↗ |
| Fidelity Funds - Global Healthcare Fund FIL Investment Management (Luxembourg) S.A. | 7.64 % | as of Apr 30, 2025 ↗ |
| Pictet - Health Pictet Asset Management (Europe) S.A. | 7.10 % | as of Sep 30, 2025 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 6.01 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Future Health Care Equity ETF Goldman Sachs ETF Trust | 5.80 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 5.06 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 5.01 % | as of Dec 31, 2025 ↗ |
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 4.69 % | as of Dec 31, 2025 ↗ |
| FINQ FIRST U.S. Large Cap AI-Managed Equity ETF Tidal Trust I | 4.39 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Medical Devices ETF iShares Trust | 4.28 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,016 | -1 | 472,666,196 | -0.3 % |
| 2026Q1 | 1,017 | -57 | 474,040,124 | -6.6 % |
| 2025Q4 | 1,074 | -17 | 507,733,722 | -4.9 % |
| 2025Q3 | 1,091 | +8 | 533,688,692 | -2.0 % |
| 2025Q2 | 1,083 | +85 | 544,419,927 | -1.4 % |
| 2025Q1 | 998 | -6 | 552,195,935 | +0.3 % |
| 2024Q4 | 1,004 | +31 | 550,450,257 | -1.3 % |
| 2024Q3 | 973 | +20 | 557,894,685 | -1.0 % |
| 2024Q2 | 953 | +25 | 563,261,052 | +4.8 % |
| 2024Q1 | 928 | -39 | 537,257,592 | -1.3 % |
| 2023Q4 | 967 | 544,103,638 |
Institutional managers
1,645 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 131,822,037 | 8.3B $ | as of Mar 31, 2026 |
| FMR LLC | 74,226,395 | 4.7B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 67,986,847 | 4.3B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 33,350,157 | 2.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 33,285,757 | 2.1B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 32,529,774 | 2B $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 24,312,352 | 1.5B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 22,756,646 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 22,266,664 | 1.4B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 18,891,624 | 1.2B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 18,833,406 | 1.2B $ | as of Mar 31, 2026 |
| Bollard Group LLC | 18,532,173 | 1.2M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 16,497,366 | 1B $ | as of Mar 31, 2026 |
| Capital World Investors | 15,309,738 | 960.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 14,824,662 | 930.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 14,498,741 | 909.8M $ | as of Mar 31, 2026 |
| Amundi | 14,122,913 | 886.2M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 13,891,668 | 871.7M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13,513,771 | 848M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 13,373,881 | 839.2M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,229,644 | 830.2M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 11,734,314 | 736.3M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10,996,572 | 716.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 10,600,766 | 665.2M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 10,057,936 | 631.1M $ | as of Mar 31, 2026 |
Declared shareholders of Boston Scientific Corp
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.47 % | 111,127,205 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 5.10 % | 75,835,683 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Boston Scientific Corp
130 funds declare 237 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Boston Scientific Corp". https://titelia.com/en/stocks/boston-scientific-corp-US1011371077